27-28 May 2026
Sanofi Campus Gentilly
3rd Edition
27-28 May 2026
Sanofi Campus Gentilly
3rd Edition
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
At Cytiva, our mission is to advance and accelerate the development of therapeutics. With 15 000 associates in more than 40 countries, we’re driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provide critical support from discovery to delivery for customers spanning researchers, emerging biotech, large-scale biopharma, and contract manufacturers.
With over 60 years of pioneering diagnostics and quality control, bioMérieux understands the challenges of ensuring product quality in the pharmaceutical industry. We proudly offer the most comprehensive portfolio of microbiology Quality Control solutions for biopharmaceuticals and Cell & Gene Therapy products. Choosing the right quality testing strategy and solution, boosts efficiency, while automation simplifies testing, reduces human error, and ensures data integrity. Rapid, simple, at-line testing of key parameters allows in-process tests closer to production, ensuring that your manufacturing process is effective and secure.
We are a global leader in serving science, providing a wide range of products and services to help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity. Our innovative technologies and solutions enable advancements in various fields, from pharmaceuticals and biotechnology to academia and government research. With a strong commitment to quality, we strive to empower our customers to make the world healthier, cleaner, and safer. Join us to explore new opportunities and collaborations at the upcoming B2B networking event.
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, ACRO delivers solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. ACROBiosystems empowers scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.
Where Proteins and Innovation Advance Biomedicine
Mourad FERHAT – mourad.ferhat@acrobiosystems.com
Etablissement Français du Sang (EFS) is offering a full range of services to make ATMPs accessible to patients for highly unmet medical needs. Based on our 4 pharmaceutical ATMPs production platforms all over France, EFS is equipped with 16 GMP class B-rooms.
EFS is fully linked with researchers and clinicians during the entire process. EFS expertise provides you with a real support on development stages, scaling up and GMP manufacturing for your preclinical and clinical batches. EFS helps yourselves on a multiple cells types such as MSC, CAR-T, iPS, hESC and HSC. Of course, we also work to assure quality controls management.
Looking forward to meeting you in Paris!
Bioproduction | Établissement français du sang
Célia Mercier – celia.mercier@efs.sante.fr
LYO-X is a consulting and modelling & simulation company specialized in PK/PD and Quantitative Systems Pharmacology for the preclinical, translational and clinical development of biologics and novel drug formats. Our specialities are drug formats at the scientific edge: bi-specifics, antibody-drug conjugates, scFv’s, nanobodies and cell-based therapies.
We have the tailored support for your unique program and help you to develop and transition best in class compounds that can stand out in a dense competitive space and tight regulatory environment.
We apply systems pharmacology for target assessment, format selection, compound design, candidate selection, dose regimen finding studies and paediatric drug development.
Microsynth is a European leader in sequencing (Sanger, NGS, and ONT), oligonucleotide synthesis, and contract research. With 30 years of experience, we offer a fast and eco-friendly sequencing service through our local laboratories in France, Austria, Germany, and Switzerland, ensuring optimized logistics and reduced turnaround times. Our expertise in DNA/RNA oligonucleotide synthesis guarantees high-quality products for all your research, diagnostic, or therapeutic needs. Finally, we assist our clients in setting up customized analytical procedures, which can be GMP-compliant, leveraging advanced technologies such as NGS and ONT sequencing, digital PCR, and cutting-edge bioinformatics solutions.
https://www.microsynth.com/home-ch.html
Microsynth info@microsynth.ch
Microsynth France info@microsynth.fr
RD-Biotech is a French CRO / CDMO providing tailor-made development and production services, for Research to clinical applications.
– From DNA vector cloning to plasmid DNA production – scalable process from R&D to GMP grades
– From mAb production to antibody sequencing and recombinant antibody development
– From pilot up to large-scale batches (up to several grams)
– And expression of recombinant proteins in multiple systems.
Scinus Cell Expansion provides technologies and process development to enable and improve cell therapy and regenerative medicine. Our main product is the SCINUS bioreactor NG, which is a closed, automated bioreactor system for the controlled cultivation of cells, supporting R&D as well as GMP processes. Combined with either the single-use Adherent or Suspension Bag it provides a scalable system for large-fold expansion. The temperature-controlled hardware enclosure houses the Single-use Bags on a unique, volume-expandable, rocking platform that provides an optimally homogenized culture environment with minimal shear stresses. Two different single use bioreactor bags can be used to cultivate adherent cells (e.g. human mesenchymal stromal cells), as well as suspension cells (e.g. T-cells) to clinically relevant numbers. Both bags can be used with the same Scinus Cell Expansion system configuration. For an illustrative animation, please check our website.
Home – Scinus Cell Expansion Netherlands bv
Safouene Fatnassi – safouene.fatnassi@scinus.com | info@scinus.com
Univercells Technologies is a global provider of innovative biomanufacturing technologies, specializing in the development and production of advanced bioreactors. These cutting-edge bioreactors are designed to achieve cost-effective viral production from R&D to commercial scales. By leveraging the strengths of process intensification and chaining, the company addresses the growing demand for viral vectors and viral vaccines. Univercells Technologies is committed to helping customers increase performance with minimized footprint and costs, while anticipating future needs.
Incorporated in Belgium in 2020, Univercells Technologies is now a part of Donaldson Company (NYSE: DCI).
For more information, visit univercellstech.com
Contact info can be Saci’s (saci.iken@donaldson.com)
The BD Group is one of the world’s top five medical technology companies, a ranking that reflects our unwavering commitment to excellence and innovation in healthcare.
BD Biosciences, a pioneer in cell analysis, offers innovative and comprehensive solutions in flow cytometry & single-cell multiomics. We support our clients throughout their bioproduct development process, from discovery to commercialization, ensuring efficiency at every stage.
BiomimX pioneers Organs on a Chip (OoC), producing the next generation of clinically relevant in-vitro models for pharmaceutical drug discovery and testing. Its proprietary platform, uBeat®, integrates microfluidics, 3D cell culture, live human cells, and mechanical stimuli to produce « Beating OoC ». These recapitulate, with unprecedented precision and predictability, clinically relevant models reflective of human pathology and physiology, amenable for drug safety and efficacy testing.
Erika Ferrari – erika.ferrari@biomimx.com
For over 70 years, Bio-Rad has supported biotech and pharmaceutical labs to develop innovative therapies. Our genomic, proteomic, and cell biology solutions help characterize iPS cells, viral and non-viral vectors, and technologies like CAR-T and CRISPR. With a global presence, Bio-Rad partners with R&D and analytical teams to increase the availability of safe and reliable cell and gene therapies.
Jean-Christophe Harlin – jean-christophe_harlin@bio-rad.com
ChemoMetec, founded in 1997 and headquartered in Allerød, Denmark, is a global leader in the design and manufacturing of automated cell counting and analysis equipment. Trusted by thousands of customers across the biotech, pharmaceutical, and academic sectors, we provide high-precision instruments that support development and production of cutting-edge therapies, like cell and gene therapy, vaccines and antibodies.
Our mission is to create reliable, easy-to-use instruments that assist our clients throughout the entire product development process. Our product range includes the NucleoCounter® series, such as the NC-202®, NC-200®, NC-3000®, and NC-250® models. These systems are renowned for their advanced image cytometry and automated cell analysis capabilities, offering consistent, reproducible results across instruments, users, and sites.
The new XcytoMatic® series represents the cutting edge in cell analysis, combining state-of-the-art optics, artificial intelligence, and an expanded cell density range. This series is designed to support all types of applications with maximum flexibility. The XM30® is a cartridge-free cell counter ideal for integration into both manual and fully automated workflows, while XM40® offers high-throughput capabilities with load-and-walk-away workflows. The Xcyto5® is a cell analyzer, which provides high-resolution cytometry data with minimal setup time, no downtime, and no clogging issues.
In addition to our instruments, we provide a complete range of consumables, including cassettes, reagents, solutions, and slides, ensuring seamless execution of protocols. Our comprehensive service plans, validation services, and training programs support customers in integrating, operating, and maintaining our equipment with confidence.
At ChemoMetec, quality is our top priority. Every stage of our design, manufacturing, and testing processes is conducted at our headquarters in Denmark. By combining automation with expert craftsmanship, we ensure the highest quality standards in every component. Our patented technologies guarantee reliable, reproducible results, whether for manual or fully automated workflows, with minimal human bias.
With a global presence that includes offices in Denmark and USA and support teams in France, the UK, Germany, the Netherlands, and China, we are able to provide world-class support. Our field application scientists and engineers ensure smooth adaptation, installation, updates, and service of our products wherever they are used.
At ChemoMetec, we’re not just advancing cell counting technology; we’re driving the future of biopharmaceutical research and development. Through collaboration with emerging biotech companies and innovation hubs, we strive to understand their unique challenges and needs. This commitment to advancing reproducible scientific methods fuels our continuous innovation, ensuring that our products deliver consistent, reliable results for all types of cells, samples, and users.
As a leading developer, manufacturer, and global supplier of laboratory products for over 100 years, Corning’s Life Sciences works with researchers and drug manufacturers seeking to increase efficiencies, reduce costs, and compress timelines. Using unique expertise in the fields of materials science, polymer surface science, cell culture, and biology, the segment provides innovative solutions that improve productivity and enable breakthrough research.
Life Sciences products include consumables (such as plastic vessels, specialty surfaces, cell culture media and serum), as well as general labware and equipment, that are used for advanced cell culture research, bioprocessing, genomics, drug discovery, microbiology and chemistry. Corning sells life sciences products under these primary brands: Corning, Falcon, Pyrex, and Axygen.
The products are marketed globally, primarily through distributors, to pharmaceutical and biotechnology companies, academic institutions, hospitals, government entities, and other facilities. Corning manufactures these products in the United States in Illinois, Maine, Massachusetts, New York, North Carolina, Utah and Virginia and outside of the U.S. in China, France, Mexico and Poland.
Contact: wangs60@corning.com
CyRISBio est une société Française basée à Saint-Genis-Laval (69) experte dans l’automatisation et l’intégration à façon de process clefs de transferts mécaniques et microfluidiques pour tubes, racks, microtubes, microplaques.
Notre panel de solutions comprend des systèmes modulaires, compacts, polyvalents et intégrables et des plateformes multi-systèmes en pilotage centralisé dans les secteurs de la santé, de l’agro-alimentaire et de la cosmétique.
Notre partenariat d’excellence sur le territoire Français avec des sociétés spécialisées comme Analytik Jena, Liconic Instrumentation et LVL-technologies nous permet de couvrir un large éventail de solutions dans le Sample Handling et le Sample Storage.
We are Fujifilm Irvine Scientific, a leading provider of cell culture media for the biopharmaceutical, cell and gene therapy, and medical research industries. With a commitment to innovation and quality, we offer a comprehensive range of advanced cell culture products and services to support our customers in advancing scientific discoveries and improving human health. Partner with us for cutting-edge solutions in cell culture technologies and bring your research to the next level.
Founded in 2003, GenoSafe is a pioneer in analytical testing of gene and cell therapy products. With 800 m2 of BSL-1, BSL-2 and BSL-3 labs located near Paris, France and the upcoming delivery of a brand-new GMP facility (hosting an additional 1,200 m2 of labs), GenoSafe offers capabilities and expertise that the gene and cell therapy industry needs to perform quality control activities according to regulatory standards. Our flexible organization and strong foundations for analytical testing help expedite the development and validation of customized or generic testing methods. GenoSafe brings its integrated quality system, qualified and trained staff, and state-of-the-art and validated equipments to comply with GxPs.
Quality Control: GenoSafe implements analytical methods to assess the different quality attributes of ATMPs: titration, identity (e.g. cell characterization), safety (e.g. replication-competent viral vectors), purity (e.g. residual plasmid/ host cell DNA) and potency/efficacy (cell-based assays).
Beyond QC activities, GenoSafe has capabilities to assist its customers accross each step of pharmaceutical development by performing GLP biodistribution/ immunogenicity analyses on preclinical samples and GCP shedding/ immunogenicity bioanalyses on clinical samples
For more than 35 years, Integrated DNA Technologies has been enabling genomics laboratories with an oligonucleotide manufacturing process with the most advanced synthesis, modification, purification, and quality control capabilities. With our founder’s dedication to innovation, the highest standards of quality & deep genomics expertise, IDT has evolved from a leading oligo manufacturer to a genomics solutions provider supporting areas such as NGS, CRISPR, synthetic biology, and PCR. www.IDT.com
At InsideTx we’re transforming nanoparticle manufacturing to release the full power of RNA-LNP therapeutics and nanomedicines.
Based in Bordeaux, France, we merge microfluidics and biotechnology to deliver a comprehensive, end-to-end nanoparticle formulation solution that streamlines your path from screening to production.
First, meet TAMARA—our all-in-one R&D platform that eliminates losses, leverages reusable microfluidic chips, and supports every phase of development, from initial screening to in-vivo studies. It’s the ultimate solution for RNA-LNP and nanomedicine research—and our users say it best: “I’m absolutely blown away by how user-friendly, efficient, and straightforward this system is!”
But that’s only the beginning. Our next-generation platform, powered by our patented technology, effortlessly scales from microliter batches to tens-of-liters continuous production at GMP quality level, all while maintaining identical nanoparticle quality & characteristics across scales. Whether you’re working with liposomes, RNA-LNPs, SLNs, PLGAs, or beyond, Inside TX propels your breakthroughs and boosts your probability of success.
Kymos Group is an analytical CRO with three European laboratories devoted to providing bioanalytical and CMC services for the life science industry throughout the entire product life cycle: from early research and development to manufacturing and commercialization. We are GLP- and GMP-certified, EMA and FDA inspected and are experts in analytical and quality control work with small molecules, biologics and oligonucleotides. Kymos provides services to clients worldwide in the pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetic and nutraceutical industries.
With over 20 years of nucleic acid delivery expertise, OZ Biosciences is confident in providing you with the best-in-class services for high quality mRNAs and LNPs production. We can synthesize custom mRNAs with diverse modifications (5’, internal and 3’ modifications), but also offer the reproducible manufacturing of safe and potent lipid nanoparticles suitable for any RNA, DNA or APIs. They will be formulated into LNPs composed by our unique patented ionizable lipids (licensing available).
Contact: smuret@ozbiosciences.com
Société de Biotechnologie indépendante depuis plus de 40 ans, Promega repose sur l’Innovation et la Recherche avec plus de 670 brevets. Nos solutions en biologie cellulaire et moléculaire accompagnent la R&D, les analyses de routine et le contrôle qualité en bioproduction. Nous collaborons avec de nombreux laboratoires et partenaires industriels. Promega maîtrise toute la chaîne, de la conception à la fabrication ISO/cGMP, avec un service de développement sur mesure (custom/OEM).
www.promega.com | marketing.france @promega.com
SGS Vitrology (Glasgow): As a world leader in biopharmaceutical testing services, we offer you a comprehensive range of biologics safety testing, including virology, cell and molecular biology, as well as microbiology and electron microscopy. As a result, we can help you to ensure product safety and meet your regulatory requirements.
Sino Biological, with an office and local stock near Frankfurt, specializes in recombinant protein production and antibody development. We provide custom reagents and services, including cell therapy solutions. From antibody development via phage display or Beacon® B cell screening to GMP-grade cytokines, we support your research. Additionally, we offer a complete range of therapeutic target proteins, including CAR-T target proteins.
https://www.sinobiological.com/ | order_eu@sinobiologicaleu.com
Innovative solutions for ADVANCED BIOPROCESSES
With over 20 years of dedicated experience in biotechnology, System-c bioprocess delivers strategic support to customers at every critical stage of their Upstream (USP) and Downstream (DSP) processes.
We leverage two core strengths: our deep understanding of the bioprocess market and our extensive product expertise. Our broad experience across numerous projects has shown that true project success stems from a comprehensive grasp of each customer’s unique challenges and needs.
Our key assets include:
– a robust network of trusted manufacturing partners
– a cohesive and complementary portfolio that spans the entire bioprocess workflow.
We excel at navigating existing constraints, optimizing investment, and introducing cutting-edge solutions made possible through our active pursuit of new technologies in products and software.
As part of the Fortil Group, System-c bioprocess is uniquely positioned to deliver advanced, tailored solutions that drive bioprocess excellence
https://www.system-c-bioprocess.com/ | bioprocess@system-c.pro
UNVEIL is a start-up developing instrumentation to accelerate the development of biologics (e.g. cell & gene therapies, RNA messenger vaccines etc.). Biologics are often transported in the body using nanometric vectors (e.g., viruses, LNP).
UNVEIL offers an optical instrument that can quickly and easily answer the question of vector loading, both in R&D and in production.
VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.
Gaetan Domin – gaetandomin@vectorbuilder.com